NCT03923530View on ClinicalTrials.gov

Pressure Assessment to Improve Outcomes After TAVR: a Registry

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

February 27, 2020

Conditions
HypertensionAortic Stenosis, CalcificQuality of LifeHeart Failure With Preserved Ejection Fraction
Interventions
DRUG

Eplerenone

Eplerenone 50 mg daily

Trial Locations (1)

32608

Malcom Randall VA Medical Center, Gainesville

All Listed Sponsors
collaborator

Malcom Randall VA Medical Center

FED

lead

North Florida Foundation for Research and Education

OTHER

NCT03923530 - Pressure Assessment to Improve Outcomes After TAVR: a Registry | Biotech Hunter | Biotech Hunter